Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
Bone mesenchymal stem cells (BMSCs) are important candidates for bone regeneration. The role of Bergenin, a C-glucoside of 4-O-methyl gallic acid obtained from the species, Bergenia, in BMSC osteogenesis has not yet been elucidated. We therefore investigated the effects of Bergenin on the osteogenes...
Saved in:
Main Authors: | Weiduo Hou (Author), Chenyi Ye (Author), Mo Chen (Author), Weixu Li (Author), Xiang Gao (Author), Rongxin He (Author), Qiang Zheng (Author), Wei Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The m6A Reader YTHDF1 Accelerates the Osteogenesis of Bone Marrow Mesenchymal Stem Cells Partly via Activation of the Autophagy Signaling Pathway
by: Xiang Gao, et al.
Published: (2023) -
Inhibition of Sirt2 Alleviates Fibroblasts Activation and Pulmonary Fibrosis via Smad2/3 Pathway
by: Hui Gong, et al.
Published: (2021) -
Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway
by: Dan Huang, et al.
Published: (2022) -
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
by: Yu Gan, et al.
Published: (2023) -
Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation
by: Kai Wang, et al.
Published: (2018)